'Rational drag design' is not a term that can be taken at face value. It implies that therapeutic agents emerge from a full molecular understanding of a disease or symptom — that drugs are designed to interact with biological targets for which structures and chemical mechanisms are known. Reality is not so clear cut. The development of treatments is much more likely to proceed hand in hand with incremental increases in basic biochemical knowledge.
展开▼
